T regulatory cells lacking CD25 are increased in MS during relapse

Area of Science:

• Immunology
• Neuroimmunology
• Autoimmunity

Background:

• Inflammatory response dysregulation is central to autoimmune diseases.
• Regulatory T cells (Tregs) are crucial for maintaining self-tolerance.
• Previous studies indicated CD25-negative Tregs are functional in autoimmunity.

Purpose of the Study:

• Investigate the role of CD25-negative Tregs in human autoimmunity, specifically multiple sclerosis (MS).
• Analyze Treg populations in relapsing-remitting MS patients during different disease phases.
• Correlate Treg levels with disease duration and effector T cell proportions.

Main Methods:

• Multicolor flow cytometry was used to analyze T cells in MS patients.
• Expression of CD3, CD4, IL2R (CD25), FoxP3, and IL7R (CD127) was measured.
• Treg levels were compared between remitting and relapsing MS patients and healthy controls.

Main Results:

• Relapsing MS patients showed increased CD25-negative FoxP3-positive Tregs compared to controls.
• Treg proportions tended to decrease with longer disease duration.
• Proportions of CD25-positive CD4+ and CD8+ effector T cells increased with disease duration.

Conclusions:

• MS patients in remission have normal Treg levels.
• Relapsing MS patients exhibit a higher proportion of CD25-negative Tregs.
• Effector T cell expansion and Treg reduction occur with disease progression in MS.